Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Endocrinology · INSR-Related Severe Insulin Resistance Syndrome

Understanding INSR-Related Severe Insulin Resistance Syndromes

At a Glance

INSR gene changes can make insulin receptors work poorly, so the body produces very high insulin while cells still struggle to use glucose. This can cause blood sugar to rise after meals and then fall too low, with severity ranging from Donohue syndrome to Type A insulin resistance.

Learning that you or your child has a severe insulin resistance syndrome caused by an INSR (Insulin Receptor) gene mutation can be overwhelming and confusing. You may be told that the body is resistant to insulin while simultaneously witnessing dangerous drops in blood sugar (hypoglycemia). This “broken thermostat” effect is a hallmark of this rare group of conditions [1][2].

Understanding these syndromes requires shifting how we typically think about insulin. In most people, insulin acts like a key that opens doors to cells, allowing sugar (glucose) to enter and provide energy. In INSR-related syndromes, the “locks” (the insulin receptors) are damaged or missing due to a genetic change [3]. Because the sugar cannot get into the cells easily, the body tries to compensate by producing extremely high amounts of insulin [2][4].

The Paradox: High Insulin and Low Blood Sugar

One of the most confusing aspects of this diagnosis is being told you have “extreme insulin resistance” while dealing with low blood sugar. This happens because the body’s glucose control system is profoundly dysregulated:

  • Overproduction: Because the cells are “hungry,” the pancreas pumps out enormous amounts of insulin [5][4].
  • The “Delayed Drop”: After eating, blood sugar may first spike very high because the insulin cannot work fast enough. However, the massive wave of insulin may eventually “overpower” the resistance in certain tissues, causing a rapid and late drop into hypoglycemia several hours after a meal in some patients [6][7].
  • Fasting Imbalance: During periods without food, the liver is supposed to release sugar to keep the brain fueled. In some patients, the high levels of background insulin—or the specific way the receptor is altered—interferes with this process, leading to low blood sugar even when not eating [8][9].

Research agrees that the primary cause is a defect in the INSR gene, which prevents the insulin receptor from forming, reaching the cell surface, or signaling correctly [10][11]. While we understand this mechanism, it remains difficult for doctors to predict exactly how a specific genetic mutation will behave in a specific person, as symptoms and patterns vary depending on residual receptor function, age, and genetics, even between family members with the same mutation [12][13].

A Spectrum of Severity

Doctors view these conditions as a continuum of overlapping phenotypes, meaning they exist on a scale from very severe to more manageable. While they are often given different names, they represent different degrees of the same underlying problem rather than strict stages [14].

  1. Donohue Syndrome: This is the most severe presentation, usually noticed before or shortly after birth [15]. It is characterized by significant growth delays, a lack of body fat (lipoatrophy), and distinct facial features [16].
  2. Rabson-Mendenhall Syndrome: This represents a middle point on the scale. It often involves severe insulin resistance, dental abnormalities, and skin changes like acanthosis nigricans (dark, velvety patches of skin) [17][16].
  3. Type A Insulin Resistance: This is generally the less severe end of the spectrum, often diagnosed around puberty [18]. It is frequently seen in non-obese individuals who may also have signs of hyperandrogenism (excess male-pattern hormones), such as acne or unusual hair growth. Type A can be genetically heterogeneous (sometimes involving other genes or no identified variant) [19][20].

Navigating the Diagnosis

It is normal to feel a range of emotions—confusion, fear, or even a sense of “invisible” illness because the patient may not appear “sick” in a traditional way [21].

  • Weight Misconceptions: A common misunderstanding is that insulin resistance is always related to weight. In these genetic syndromes, insulin resistance occurs regardless of body size; in fact, many patients are quite thin [22][23].
  • Diagnostic Confusion: Many patients, especially those with Type A, are initially misdiagnosed with more common conditions like Polycystic Ovary Syndrome (PCOS) or Type 1 Diabetes [18][24]. It often takes seeing an endocrinologist who specializes in rare metabolic disorders to find the correct answer.

While the science of genetics helps explain the “why,” living with an INSR-related syndrome requires a specialized care team to help manage the “how” of daily blood sugar balance [25][26]. Growing research into how different mutations affect the receptor is helping doctors better understand this spectrum every year [27][28].

Common questions in this guide

Why can INSR-related disease cause both insulin resistance and low blood sugar?
An INSR change can make cells respond poorly to insulin, so the pancreas releases unusually large amounts to compensate. Blood sugar may rise after a meal and then drop later when the large insulin response takes effect; high insulin can also interfere with the liver’s release of glucose during fasting.
What does an INSR gene mutation do?
It may prevent the insulin receptor from forming normally, reaching the cell surface, or sending its signal correctly. The effect varies by mutation and by how much receptor function remains, so symptoms can differ with age and even among relatives with the same mutation.
How do Donohue syndrome, Rabson-Mendenhall syndrome, and Type A insulin resistance differ?
They are overlapping presentations on a spectrum rather than strict stages. Donohue syndrome is generally the most severe and begins very early, Rabson-Mendenhall syndrome is an intermediate presentation, and Type A insulin resistance is often milder, recognized around puberty, and may involve acne or unusual hair growth.
Can someone with INSR-related insulin resistance be thin?
Yes. These genetic syndromes can cause severe insulin resistance regardless of body size, and many affected people are thin or not obese. Body weight alone cannot rule out the condition.
How is INSR-related severe insulin resistance identified?
Clinicians may review symptoms, blood sugar and insulin patterns, age of onset, physical findings, and genetic results to identify an INSR-related condition. A specialist in endocrinology or rare metabolic disorders can help distinguish it from conditions such as PCOS or type 1 diabetes.
Could continuous glucose monitoring help with INSR-related hypoglycemia?
Continuous glucose monitoring, or CGM, can show glucose changes throughout the day and may help reveal patterns such as a delayed drop after eating. Whether it is useful depends on the patient’s age, symptoms, and care plan, so discuss it with the treating endocrinologist.
How might INSR-related disease affect a child’s growth or puberty?
Severe forms, especially Donohue syndrome, can involve significant growth delay, while Type A insulin resistance is often recognized around puberty and may include signs of excess male-pattern hormones. The effect on a child’s growth, development, and puberty varies, so it should be followed by the child’s care team.

Get notified when new evidence is published on Hyperinsulinism due to INSR deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (28)
  1. 1

    Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance.

    Marcelino do Nascimento R, Dos Santos A, Guadagnini D, et al.

    Frontiers in endocrinology 2026; (17()):1716020 doi:10.3389/fendo.2026.1716020.

    PMID: 42181197
  2. 2

    Comprehensive assessment of the genotype-phenotype spectrum and treatment for monoallelic insulin receptoropathy in a cohort of 505 people.

    Brown RJ, Xu J, Luan J, et al.

    Research square 2026; doi:10.21203/rs.3.rs-10884175/v1.

    PMID: 42856426
  3. 3

    New classification and diagnostic criteria for insulin resistance syndrome.

    Ogawa W, Araki E, Ishigaki Y, et al.

    Diabetology international 2022; (13(2)):337-343 doi:10.1007/s13340-022-00570-5.

    PMID: 35463863
  4. 4

    Case Report: A Chinese Family of Type A Insulin Resistance Syndrome With Diabetes Mellitus, With a Novel Heterozygous Missense Mutation of the Insulin Receptor Gene.

    You W, Yang J, Wang L, et al.

    Frontiers in endocrinology 2022; (13()):895424 doi:10.3389/fendo.2022.895424.

    PMID: 35634501
  5. 5

    Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation.

    Innaurato S, Brierley GV, Grasso V, et al.

    Pediatric diabetes 2018; (19(4)):670-674 doi:10.1111/pedi.12632.

    PMID: 29411486
  6. 6

    Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation

    Poon SWY, Chung BHY, Wong MSC, Tsang AMC

    Journal of clinical research in pediatric endocrinology 2025; (17(1)):115-119 doi:10.4274/jcrpe.galenos.2023.2022-12-10.

    PMID: 37074094
  7. 7

    Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys).

    Prehn EL, Crowley M, Fennell D, et al.

    Endocrinology, diabetes & metabolism case reports 2025; (2025(1)).

    PMID: 39922186
  8. 8

    Case Report: Functional characterization of a missense variant in INSR associated with hypoketotic hypoglycemia.

    Guzman H, Mitteer LM, Chen P, et al.

    Frontiers in pediatrics 2024; (12()):1493280 doi:10.3389/fped.2024.1493280.

    PMID: 39483531
  9. 9

    Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion.

    Verdecchia F, Akcan N, Dastamani A, et al.

    Hormone research in paediatrics 2020; (93(6)):396-401 doi:10.1159/000510462.

    PMID: 33040071
  10. 10

    A de novo INSR variant in Type A insulin resistance syndrome: familial investigation and genetic implications.

    Lin X, Xu ZY, Xie LJ, et al.

    Gene 2026; (979()):149934 doi:10.1016/j.gene.2025.149934.

    PMID: 41360184
  11. 11

    Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases.

    Tsuji-Hosokawa A, Takasawa K, Nomura R, et al.

    Pediatric diabetes 2017; (18(8)):917-924 doi:10.1111/pedi.12508.

    PMID: 28181734
  12. 12

    Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.

    Hosoe J, Kadowaki H, Miya F, et al.

    Diabetes 2017; (66(10)):2713-2723 doi:10.2337/db17-0301.

    PMID: 28765322
  13. 13

    Family with two novel in cis INSR gene variants: Phenotypic evolution with age.

    Sotiriou G, Mertzanian A, Raptopoulou ME, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2026; (35(4)):351-356 doi:10.1297/cpe.2026-0014.

    PMID: 42825299
  14. 14

    Syndrome of Congenital Insulin Resistance Caused by a Novel INSR Gene Mutation

    Rojek A, Wikiera B, Noczynska A, Niedziela M

    Journal of clinical research in pediatric endocrinology 2023; (15(3)):312-317 doi:10.4274/jcrpe.galenos.2021.2021.0256.

    PMID: 34965699
  15. 15

    Donohue syndrome: a new case with a new complication.

    Odeh R, Alassaf A, Al-Qudah AA

    Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(7-8)):951-4.

    PMID: 25741786
  16. 16

    A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome.

    Ben Abdelaziz R, Ben Chehida A, Azzouz H, et al.

    European journal of medical genetics 2016; (59(1)):16-9.

    PMID: 26691667
  17. 17

    Rabson-Mendenhall Syndrome: Analysis of the Clinical Characteristics and Gene Mutations in 42 Patients.

    Gong W, Chen W, Dong J, Liao L

    Journal of the Endocrine Society 2024; (8(8)):bvae123 doi:10.1210/jendso/bvae123.

    PMID: 38957655
  18. 18

    Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.

    Lin L, Chen C, Fang T, et al.

    Journal of medical case reports 2019; (13(1)):347 doi:10.1186/s13256-019-2304-4.

    PMID: 31771632
  19. 19

    Diagnostic and management challenges from childhood, puberty through to transition in severe insulin resistance due to insulin receptor mutations.

    Wei C, Burren CP

    Pediatric diabetes 2017; (18(8)):835-838 doi:10.1111/pedi.12486.

    PMID: 28093873
  20. 20

    A New Mutation of the INSR Gene in a 13-Year-Old Girl with Severe Insulin Resistance Syndrome in China.

    Jin J, Liang X, Wei J, Xu L

    BioMed research international 2021; (2021()):8878149 doi:10.1155/2021/8878149.

    PMID: 33728347
  21. 21

    "We're stuck with what we've got": The impact of lipodystrophy on body image.

    Adams C, Stears A, Savage D, Deaton C

    Journal of clinical nursing 2018; (27(9-10)):1958-1968 doi:10.1111/jocn.14342.

    PMID: 29516553
  22. 22

    A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism.

    Krishnamurthy M, Pingul MM

    Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(10)):1201-1205.

    PMID: 27505086
  23. 23

    Can obesity exacerbate hyperinsulinaemia in the presence of the mutation of an insulin receptor gene?

    Calcaterra V, Zuccotti G, Mari A, et al.

    Clinical obesity 2023; (13(6)):e12619 doi:10.1111/cob.12619.

    PMID: 37717597
  24. 24

    A novel heterozygous mutation in the insulin receptor gene presenting with type A severe insulin resistance syndrome.

    Aghababaie AS, Ford-Adams M, Buchanan CR, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(6)):809-812 doi:10.1515/jpem-2019-0503.

    PMID: 32441669
  25. 25

    Rabson-Mendenhall Syndrome in a brother-sister pair in Kuwait: Diagnosis and 5 year follow up.

    Al-Kandari H, Al-Abdulrazzaq D, Al-Jaser F, et al.

    Primary care diabetes 2021; (15(1)):175-177 doi:10.1016/j.pcd.2020.07.012.

    PMID: 32843252
  26. 26

    Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management.

    Iqbal J, Jiang HL, Wu HX, et al.

    Genes & diseases 2023; (10(5)):1846-1856 doi:10.1016/j.gendis.2022.03.016.

    PMID: 37492723
  27. 27

    An INSR-BECN1-KIAA0825 complex prevents hepatocytic insulin receptor secretion via extracellular vesicles against monogenic diabetes.

    Kuramoto K, Chen M, He C

    bioRxiv : the preprint server for biology 2026; doi:10.64898/2026.09.13.751259.

    PMID: 42779891
  28. 28

    Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.

    Zhou Q, Yu J, Yuan X, et al.

    Frontiers in endocrinology 2021; (12()):606964 doi:10.3389/fendo.2021.606964.

    PMID: 33995269

This page is for informational purposes only and does not constitute medical advice. An endocrinologist or genetics specialist should interpret your or your child’s INSR results and blood sugar pattern.

Guide contents Hyperinsulinism due to INSR deficiency
Research & Literature
02 Warning Signs and Emergency Presentations